Smith Mark Douglas sold JAZZ
August 8, 2025 · Form 4 insider transaction
Smith Mark Douglas sold 1,805 shares of Jazz Pharmaceuticals plc at $111.25 per share, a transaction worth $200.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,805
Price
$111.25
Total value
$200.8K
InsiderSmith Mark Douglas
Role—
SecurityOrdinary Shares
Transaction codeF: Shares withheld for taxes
Transaction dateAugust 8, 2025
Filing dateAugust 11, 2025
Shares owned after10,837
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.